Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A SARS-CoV-2 Infection Model in Mice Demonstrates Protection by Neutralizing Antibodies
Ahmed O. Hassan, James Brett Case, Emma S. Winkler, et al.
Cell (2020) Vol. 182, Iss. 3, pp. 744-753.e4
Open Access | Times Cited: 538

Showing 101-125 of 538 citing articles:

The Roborovski Dwarf Hamster Is A Highly Susceptible Model for a Rapid and Fatal Course of SARS-CoV-2 Infection
Jakob Trimpert, Daria Vladimirova, Kristina Dietert, et al.
Cell Reports (2020) Vol. 33, Iss. 10, pp. 108488-108488
Open Access | Times Cited: 93
Natural and Experimental SARS-CoV-2 Infection in Domestic and Wild Animals
David A. Meekins, Natasha N. Gaudreault, Jüergen A. Richt
Viruses (2021) Vol. 13, Iss. 10, pp. 1993-1993
Open Access | Times Cited: 93
A Brief Review on Dna Vaccines in the Era of COVID-19
Maryam Shafaati, Massoud Saidijam, Meysam Soleimani, et al.
Future Virology (2021) Vol. 17, Iss. 1, pp. 49-66
Open Access | Times Cited: 91
Engineering Extracellular Vesicles Enriched with Palmitoylated ACE2 as COVID‐19 Therapy
Feng Xie, Peng Su, Ting Pan, et al.
Advanced Materials (2021) Vol. 33, Iss. 49
Open Access | Times Cited: 88
The SARS-CoV-2 B.1.1.529 Omicron virus causes attenuated infection and disease in mice and hamsters
Michael Diamond, Peter Halfmann, Tadashi Maemura, et al.
Research Square (Research Square) (2021)
Open Access | Times Cited: 85
A Comprehensive Review of Animal Models for Coronaviruses: SARS-CoV-2, SARS-CoV, and MERS-CoV
Ashutosh Singh, Rahul Singh, Phulen Sarma, et al.
Virologica Sinica (2020) Vol. 35, Iss. 3, pp. 290-304
Open Access | Times Cited: 82
An ACE2 Microbody Containing a Single Immunoglobulin Fc Domain Is a Potent Inhibitor of SARS-CoV-2
Takuya Tada, Fan Chen, Jennifer Chen, et al.
Cell Reports (2020) Vol. 33, Iss. 12, pp. 108528-108528
Open Access | Times Cited: 81
Substrains matter in phenotyping of C57BL/6 mice
Kazuyuki Mekada, Atsushi Yoshiki
EXPERIMENTAL ANIMALS (2021) Vol. 70, Iss. 2, pp. 145-160
Open Access | Times Cited: 81
Introduction of Two Prolines and Removal of the Polybasic Cleavage Site Lead to Higher Efficacy of a Recombinant Spike-Based SARS-CoV-2 Vaccine in the Mouse Model
Fatima Amanat, Shirin Strohmeier, Raveen Rathnasinghe, et al.
mBio (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 79
Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?
Gregory Milne, Thomas Hames, Chris J. Scotton, et al.
The Lancet Respiratory Medicine (2021) Vol. 9, Iss. 12, pp. 1450-1466
Open Access | Times Cited: 78
Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016
Tyler N. Starr, Allison J. Greaney, Adam S. Dingens, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 77
Differences in the Concentration of Anti-SARS-CoV-2 IgG Antibodies Post-COVID-19 Recovery or Post-Vaccination
Andrzej Tretyn, Joanna Szczepanek, Monika Skorupa, et al.
Cells (2021) Vol. 10, Iss. 8, pp. 1952-1952
Open Access | Times Cited: 77
Vaccine formulations in clinical development for the prevention of severe acute respiratory syndrome coronavirus 2 infection
Cole J. Batty, Mark T. Heise, Eric M. Bachelder, et al.
Advanced Drug Delivery Reviews (2020) Vol. 169, pp. 168-189
Open Access | Times Cited: 76
Viral infections in humans and mice with genetic deficiencies of the type I IFN response pathway
Isabelle Meyts, Jean‐Laurent Casanova
European Journal of Immunology (2021) Vol. 51, Iss. 5, pp. 1039-1061
Open Access | Times Cited: 74
Markers of Polyfunctional SARS-CoV-2 Antibodies in Convalescent Plasma
Harini Natarajan, Andrew R. Crowley, Savannah E. Butler, et al.
mBio (2021) Vol. 12, Iss. 2
Open Access | Times Cited: 72
SARS-CoV-2 Causes Lung Infection without Severe Disease in Human ACE2 Knock-In Mice
Emma S. Winkler, Rita E. Chen, Fahmida Alam, et al.
Journal of Virology (2021) Vol. 96, Iss. 1
Open Access | Times Cited: 72
Infection of wild-type mice by SARS-CoV-2 B.1.351 variant indicates a possible novel cross-species transmission route
Ting Pan, Ran Chen, Xin He, et al.
Signal Transduction and Targeted Therapy (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 71
The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates
Dapeng Li, Robert J. Edwards, Kartik Manne, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 70
SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients
Roberto Gozalbo‐Rovira, Estela Giménez, Víctor Latorre, et al.
Journal of Clinical Virology (2020) Vol. 131, pp. 104611-104611
Open Access | Times Cited: 69
In Vitro and In Vivo Models for Studying SARS-CoV-2, the Etiological Agent Responsible for COVID-19 Pandemic
Rafael Borges Rosa, Willyenne Marília Dantas, Jéssica Catarine Frutuoso do Nascimento, et al.
Viruses (2021) Vol. 13, Iss. 3, pp. 379-379
Open Access | Times Cited: 69
Omicron variant: Current insights and future directions
Rashmi Rana, Ravi Kant, Rohit Singh Huirem, et al.
Microbiological Research (2022) Vol. 265, pp. 127204-127204
Open Access | Times Cited: 66
Animal models for SARS-CoV-2
Chung-Young Lee, Anice C. Lowen
Current Opinion in Virology (2021) Vol. 48, pp. 73-81
Open Access | Times Cited: 65
The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants
Chang Liu, Daming Zhou, Rungtiwa Nutalai, et al.
Cell Host & Microbe (2021) Vol. 30, Iss. 1, pp. 53-68.e12
Open Access | Times Cited: 63
Post-exposure protection of SARS-CoV-2 lethal infected K18-hACE2 transgenic mice by neutralizing human monoclonal antibody
Ronit Rosenfeld, Tal Noy-Porat, Adva Mechaly, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 59
SARS-CoV-2: vaccines in the pandemic era
Dandan Li, Qihan Li
Military Medical Research (2021) Vol. 8, Iss. 1
Open Access | Times Cited: 57

Scroll to top